Related Experiment Video
Updated: May 3, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Early trauma induced coagulopathy (ETIC): prevalence across the injury spectrum
Jana B A MacLeod1, Anne M Winkler2, Cameron C McCoy3
1Study completed while author at the Department of Surgery, Emory University School of Medicine, Atlanta, GA, United States; Karen Hospital, Department of Surgery, Nairobi, Kenya.
Insights
Early trauma-induced coagulopathy (ETIC) affects 16.3% of trauma patients and is linked to increased mortality, even in mild injuries. Understanding ETIC is crucial for improving trauma patient outcomes.
Area of Science:
- Trauma Care
- Hematology
- Emergency Medicine
Background:
- Early trauma-induced coagulopathy (ETIC), also known as acute traumatic coagulopathy, is a hypothesized early post-injury condition defined by elevated prothrombin time (PT) upon admission.
- Previous studies primarily focused on severely injured or hypotensive patients.
- This study aimed to investigate ETIC prevalence across all injury severities.
Purpose of the Study:
- To determine the prevalence of ETIC in a large, unselected trauma cohort.
- To identify risk patterns associated with ETIC.
- To evaluate the relationship between ETIC and patient survival.
Main Methods:
- Prospective cohort study conducted at a Level I trauma center.
- Inclusion of all patients admitted for 24 hours or longer.
- Collection of demographics, injury details, vital signs, and fluid/blood administration data.
Main Results:
- 701 patients were analyzed, with an overall mortality of 7.3%.
- 16.3% of patients exhibited ETIC, which was independently associated with increased mortality (OR 1.10 per 0.10s PT increase, p=0.001).
- ETIC was present in 11.7% of mildly injured patients (ISS < 16) without physiological derangement or resuscitation.
Conclusions:
- ETIC is an early, primary coagulopathy occurring in 16.3% of trauma admissions.
- ETIC is independently associated with higher mortality, irrespective of injury severity, vital signs, or head injury.
- Further research into ETIC is essential for improving outcomes in trauma patients.
Introduction:
Newer studies have hypothesised about a coagulopathy that occurs early after trauma, early trauma induced coagulopathy, ETIC, and is defined by an elevated admission prothrombin time (PT). Also, referred to by some authors as acute traumatic coagulopathy, it has been most often studied in cohorts of severely injured or hypotensive patients. However, we wanted to prospectively investigate ETIC in a large all-comers cohort to confirm its prevalence across the entire spectrum of injury, to evaluate its risk pattern and to determine a possible relationship to reduced survival.
Methods:
We conducted a prospective cohort study at a Level I trauma centre from July 15, 2008 to November 15, 2009. Demographics, injury mechanism, time from injury and to hospital arrival, fluid and blood administration and vital signs were collected at hospital arrival and to the time of first blood sample collection for all patients admitted for 24h or longer. Our primary outcome was the incidence of mortality by the 28th hospital day, referred to as 28 day in-hospital mortality.
Results:
701 patients were included in the final study cohort. There was 75.3% male, 25.7% penetrating, with a mean age of 39 years. The overall mortality was 7.3%. ETIC occurred in 114 patients (16.3%) and was found to be independently associated with death (odds of death (per 0.10s increase in PT): 1.10, p=0.001). ETIC patients, as a group, were more severely injured, had more hypotension and head injury and used more crystalloid and blood products than non-ETIC patients. However, even mildly injured patients, who had an ISS<16, normal RTS score, and no fluid resuscitation, had an ETIC prevalence of 11.7% (11/94).
Conclusions:
ETIC is an early, primary post-injury coagulopathy that occurs in 16.3% of admitted trauma patients. It is associated with an increase in mortality, even when controlling for crystalloids, vital signs, injury severity and head injury. It can also be found in approximately 11% of mildly injured patients (patients without physiological derangement or blood product administration). Therefore, further elucidation of ETIC is strategic to impacting trauma patient outcome.
Related Concept Videos
Traumatic Brain Injury l: Introduction
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Hemorrhagic Stroke ll: Pathophysiology
Cellular Injury I: Introduction

